Compare $ALT vs $MNPR | Chartloom

Compare

$ALT vs $MNPR

Altimmune Inc · Monopar Therapeutics Inc

ALT

Altimmune Inc

MNPR

Monopar Therapeutics Inc

Compare $ALT vs $MNPR

Comparing Altimmune Inc and Monopar Therapeutics Inc

ALTAltimmune Inc

MNPRMonopar Therapeutics Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

MNPRMonopar Therapeutics Inc

Market cap

$529M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

48.37x

Rev growth (TTM)

—

YTD performance

19.6%

52W performance

-19.9%

FCF yield

-2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

MNPR

Detailed metrics comparison

ALT

Altimmune Inc

MNPR

Monopar Therapeutics Inc

Market Cap

ALT$508M

MNPR$529M

Enterprise Value

ALT$479M

MNPR$476M

Price

ALT$2.61

MNPR$78.96

P/E Ratio

ALTN/A

MNPRN/A

P/S Ratio

ALT16,373.12x

MNPR0.00x

EV/Sales

ALT15,461.31x

MNPR0.00x

EV/EBITDA

ALT0.00x

MNPR0.00x

P/B Ratio

ALT1.12x

MNPR4.00x

P/FCF Ratio

ALTN/A

MNPRN/A

EV/FCF

ALT-6.26x

MNPR-39.10x

PEG Ratio

ALTN/A

MNPRN/A

Forward P/E (NTM)

ALTN/A

MNPRN/A

Forward P/S (NTM)

ALTN/A

MNPR48.37x

Revenue (TTM)

ALT$31K

MNPR$0

Revenue Growth (YoY)

ALT55.0%

MNPRN/A

Forward Rev Growth

ALT217.1%

MNPR327.6%

Gross Margin (TTM)

ALT0.0%

MNPR0.0%

Operating Margin (TTM)

ALT0.0%

MNPR0.0%

EBITDA Margin (TTM)

ALT-322987.1%

MNPR0.0%

Net Margin (TTM)

ALT-296000.0%

MNPR0.0%

FCF Margin (TTM)

ALT-246974.2%

MNPRN/A

Net Income (TTM)

ALT$-92M

MNPR$-18M

FCF (TTM)

ALT$-77M

MNPR$-12M

EPS (TTM)

ALT-$0.49

MNPR-$2.09

ROE (TTM)

ALT-3141.0%

MNPR-1308.0%

ROA (TTM)

ALT-2696.0%

MNPR-1279.0%

ROIC (TTM)

ALT-2853.0%

MNPR-1308.0%

Cash

ALT$63M

MNPR$53M

Debt

ALT$35M

MNPR$0

Net Cash/Debt

ALT$28M

MNPR$53M

Current Ratio (TTM)

ALT26.78x

MNPR33.56x

Quick Ratio (TTM)

ALT26.37x

MNPR33.56x

Debt/Equity (TTM)

ALT0.07x

MNPR0.00x

Debt/Assets (TTM)

ALT0.0%

MNPR0.0%

Interest Coverage (TTM)

ALTN/A

MNPRN/A

Net Debt/EBITDA (TTM)

ALT0.00x

MNPR0.00x

Beta

ALT0.06

MNPR1.54

52W Performance

ALT-33.6%

MNPR-19.9%

YTD Performance

ALT-25.6%

MNPR19.6%

% from 52W High

ALT-59.5%

MNPR-36.7%

% from 52W Low

ALT2.4%

MNPR57.7%

Asset Turnover (TTM)

ALT0.00x

MNPR0.00x

FCF Yield (TTM)

ALT-15.1%

MNPR-2.3%

Earnings Yield (TTM)

ALT-18.1%

MNPR-3.4%

Dividend Yield (TTM)

ALTN/A

MNPRN/A

Rule of 40

ALT-246,919.2

MNPR0.0

EV/GP/RG

ALTN/A

MNPRN/A

Ticker research

View ALT research View MNPR research

Metric	ALT Altimmune Inc	MNPR Monopar Therapeutics Inc
Market & Valuation
Market Cap	$508M	$529M
Enterprise Value	$479M	$476M
Price	$2.61	$78.96
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	4.00x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-39.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	48.37x
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	327.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-18M
FCF (TTM)	$-77M	$-12M
EPS (TTM)	-$0.49	-$2.09
ROE (TTM)	-3141.0%	-1308.0%
ROA (TTM)	-2696.0%	-1279.0%
ROIC (TTM)	-2853.0%	-1308.0%
Financial Health
Cash	$63M	$53M
Debt	$35M	$0
Net Cash/Debt	$28M	$53M
Current Ratio (TTM)	26.78x	33.56x
Quick Ratio (TTM)	26.37x	33.56x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.54
52W Performance	-33.6%	-19.9%
YTD Performance	-25.6%	19.6%
% from 52W High	-59.5%	-36.7%
% from 52W Low	2.4%	57.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-2.3%
Earnings Yield (TTM)	-18.1%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View MNPR research

Valuation

P/S Ratio

MNPR

0.00x

ALT

16,373.12x

EV/FCF

MNPR

-39.10x

ALT

-6.26x

Growth & revenue

Revenue Growth TTM

ALT

55.0%

Forward Revenue Growth

MNPR

327.6%

ALT

217.1%

Profitability & performance

Gross Margin

ALT

0.0%

MNPR

0.0%

ROE

MNPR

-1308.0%

ALT

-3141.0%

FCF Yield %

MNPR

-2.3%

ALT

-15.1%

52-Week Performance

MNPR

-19.9%

ALT

-33.6%

Detailed metrics comparison

ALT

Altimmune Inc

MNPR

Monopar Therapeutics Inc

Market Cap

ALT$508M

MNPR$529M

Enterprise Value

ALT$479M

MNPR$476M

Price

ALT$2.61

MNPR$78.96

P/E Ratio

ALTN/A

MNPRN/A

P/S Ratio

ALT16,373.12x

MNPR0.00x

EV/Sales

ALT15,461.31x

MNPR0.00x

EV/EBITDA

ALT0.00x

MNPR0.00x

P/B Ratio

ALT1.12x

MNPR4.00x

P/FCF Ratio

ALTN/A

MNPRN/A

EV/FCF

ALT-6.26x

MNPR-39.10x

PEG Ratio

ALTN/A

MNPRN/A

Forward P/E (NTM)

ALTN/A

MNPRN/A

Forward P/S (NTM)

ALTN/A

MNPR48.37x

Revenue (TTM)

ALT$31K

MNPR$0

Revenue Growth (YoY)

ALT55.0%

MNPRN/A

Forward Rev Growth

ALT217.1%

MNPR327.6%

Gross Margin (TTM)

ALT0.0%

MNPR0.0%

Operating Margin (TTM)

ALT0.0%

MNPR0.0%

EBITDA Margin (TTM)

ALT-322987.1%

MNPR0.0%

Net Margin (TTM)

ALT-296000.0%

MNPR0.0%

FCF Margin (TTM)

ALT-246974.2%

MNPRN/A

Net Income (TTM)

ALT$-92M

MNPR$-18M

FCF (TTM)

ALT$-77M

MNPR$-12M

EPS (TTM)

ALT-$0.49

MNPR-$2.09

ROE (TTM)

ALT-3141.0%

MNPR-1308.0%

ROA (TTM)

ALT-2696.0%

MNPR-1279.0%

ROIC (TTM)

ALT-2853.0%

MNPR-1308.0%

Cash

ALT$63M

MNPR$53M

Debt

ALT$35M

MNPR$0

Net Cash/Debt

ALT$28M

MNPR$53M

Current Ratio (TTM)

ALT26.78x

MNPR33.56x

Quick Ratio (TTM)

ALT26.37x

MNPR33.56x

Debt/Equity (TTM)

ALT0.07x

MNPR0.00x

Debt/Assets (TTM)

ALT0.0%

MNPR0.0%

Interest Coverage (TTM)

ALTN/A

MNPRN/A

Net Debt/EBITDA (TTM)

ALT0.00x

MNPR0.00x

Beta

ALT0.06

MNPR1.54

52W Performance

ALT-33.6%

MNPR-19.9%

YTD Performance

ALT-25.6%

MNPR19.6%

% from 52W High

ALT-59.5%

MNPR-36.7%

% from 52W Low

ALT2.4%

MNPR57.7%

Asset Turnover (TTM)

ALT0.00x

MNPR0.00x

FCF Yield (TTM)

ALT-15.1%

MNPR-2.3%

Earnings Yield (TTM)

ALT-18.1%

MNPR-3.4%

Dividend Yield (TTM)

ALTN/A

MNPRN/A

Rule of 40

ALT-246,919.2

MNPR0.0

EV/GP/RG

ALTN/A

MNPRN/A

Ticker research

View ALT research View MNPR research

Metric	ALT Altimmune Inc	MNPR Monopar Therapeutics Inc
Market & Valuation
Market Cap	$508M	$529M
Enterprise Value	$479M	$476M
Price	$2.61	$78.96
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	4.00x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-39.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	48.37x
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	327.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-18M
FCF (TTM)	$-77M	$-12M
EPS (TTM)	-$0.49	-$2.09
ROE (TTM)	-3141.0%	-1308.0%
ROA (TTM)	-2696.0%	-1279.0%
ROIC (TTM)	-2853.0%	-1308.0%
Financial Health
Cash	$63M	$53M
Debt	$35M	$0
Net Cash/Debt	$28M	$53M
Current Ratio (TTM)	26.78x	33.56x
Quick Ratio (TTM)	26.37x	33.56x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.54
52W Performance	-33.6%	-19.9%
YTD Performance	-25.6%	19.6%
% from 52W High	-59.5%	-36.7%
% from 52W Low	2.4%	57.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-2.3%
Earnings Yield (TTM)	-18.1%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View MNPR research